Published in Cancer Weekly, December 3rd, 2002
Scientists know that angiogenesis, or new vessel growth, encourages the progression of HCC. However, few studies have looked at whether serum levels of endostatin, a natural angiogenesis inhibitor, may also be related to the presence of HCC. A study of HCC in Japan patients suggests that it is.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.